202 related articles for article (PubMed ID: 20338404)
1. Re: contrast-induced nephropathy: are there differences between low osmolar and iso-osmolar iodinated contrast media?
Downes MO; Nicholson A
Clin Radiol; 2010 Apr; 65(4):343-4; author reply 344-5. PubMed ID: 20338404
[No Abstract] [Full Text] [Related]
2. Contrast-induced nephropathy: are there differences between low osmolar and iso-osmolar iodinated contrast media?
Morcos SK
Clin Radiol; 2009 May; 64(5):468-72. PubMed ID: 19348841
[TBL] [Abstract][Full Text] [Related]
3. [Iodinated contrast media and nephropathy. Estimated creatinine clearance for better assessment of renal function and dosage].
Nyman U; Hietala SO; Hellström M; Aspelin P; Björkdahl P; Albrechtsson U; Magnusson A; Måre K; Törnquist C; Ringertz H; Sterner G; Westberg G; Berne C
Ugeskr Laeger; 2004 Jun; 166(26-31):2566-72. PubMed ID: 15285166
[No Abstract] [Full Text] [Related]
4. Intravenous Contrast-Induced Nephropathy-The Rise and Fall of a Threatening Idea.
Luk L; Steinman J; Newhouse JH
Adv Chronic Kidney Dis; 2017 May; 24(3):169-175. PubMed ID: 28501080
[TBL] [Abstract][Full Text] [Related]
5. [Contrast medica nephropathy. Better understanding of risk markers and follow up needed].
Sterner G; Hellström M; Lagerqvist B; Aspelin P; Nyman U
Lakartidningen; 2009 Jun 24-Jul 7; 106(26-27):1737-42. PubMed ID: 19731735
[No Abstract] [Full Text] [Related]
6. Contrast nephropathy: isosmolar and low-osmolar contrast media.
Detrenis S; Meschi M; Savazzi G
J Am Coll Cardiol; 2007 Feb; 49(8):922; author reply 922-3. PubMed ID: 17320755
[No Abstract] [Full Text] [Related]
7. Low-osmolar and iso-osmolar contrast media in contrast-induced nephropathy.
Savazzi G; Detrenis S; Meschi M; Musini S
Am J Kidney Dis; 2005 Feb; 45(2):435; author reply 435. PubMed ID: 15685526
[No Abstract] [Full Text] [Related]
8. Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality.
Rudnick MR; Goldfarb S
Rev Cardiovasc Med; 2003; 4 Suppl 5():S28-33. PubMed ID: 14668707
[TBL] [Abstract][Full Text] [Related]
9. Nephrotoxic effects in high-risk patients undergoing angiography.
Aspelin P; Aubry P; Fransson SG; Strasser R; Willenbrock R; Berg KJ;
N Engl J Med; 2003 Feb; 348(6):491-9. PubMed ID: 12571256
[TBL] [Abstract][Full Text] [Related]
10. Contrast-induced acute kidney injury in patients with renal dysfunction undergoing a coronary procedure and receiving non-ionic low-osmolar versus iso-osmolar contrast media.
Alexopoulos E; Spargias K; Kyrzopoulos S; Manginas A; Pavlides G; Voudris V; Lerakis S; McLean DS; Cokkinos DV
Am J Med Sci; 2010 Jan; 339(1):25-30. PubMed ID: 19996728
[TBL] [Abstract][Full Text] [Related]
11. Renal safety of iodixanol.
McCullough PA
Expert Rev Cardiovasc Ther; 2006 Sep; 4(5):655-61. PubMed ID: 17081087
[TBL] [Abstract][Full Text] [Related]
12. High incidence of nephropathy in neurosurgical patients after intra-arterial administration of low-osmolar and iso-osmolar contrast media.
Serafin Z; Karolkiewicz M; Gruszka M; Strózecki P; Lasek W; Odrowaz-Sypniewska G; Manitius J; Beuth W
Acta Radiol; 2011 May; 52(4):422-9. PubMed ID: 21498279
[TBL] [Abstract][Full Text] [Related]
13. Iso- versus low-osmolar contrast media and contrast medium-induced nephropathy.
Pering C; Lengsfeld P; Seidensticker P
Radiology; 2009 Jan; 250(1):298-9; author reply 299. PubMed ID: 19092102
[No Abstract] [Full Text] [Related]
14. The impact of iso-osmolar contrast use in emergent percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Kanei Y; Ayabe K; Ratcliffe J; Vales L; Nakra N; Friedman P; Fox J
J Invasive Cardiol; 2011 Nov; 23(11):448-50. PubMed ID: 22045075
[TBL] [Abstract][Full Text] [Related]
15. The editor's roundtable: contrast agents and risk for contrast-induced nephropathy.
Friedewald VE; Goldfarb S; Laskey WK; Vetrovec GW; Roberts WC
Am J Cardiol; 2011 Jun; 107(12):1848-55. PubMed ID: 21640219
[No Abstract] [Full Text] [Related]
16. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
Mehran R; Nikolsky E; Kirtane AJ; Caixeta A; Wong SC; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Kim YH; Fahy M; Dangas GD
JACC Cardiovasc Interv; 2009 May; 2(5):415-21. PubMed ID: 19463464
[TBL] [Abstract][Full Text] [Related]
17. Contrast-induced nephropathy.
Kabalan SN; El-Imad BG; Geara AS
J Med Liban; 2007; 55(1):29-38. PubMed ID: 17489305
[No Abstract] [Full Text] [Related]
18. The challenges in assessing contrast-induced nephropathy: where are we now?
Davenport MS; Cohan RH; Khalatbari S; Ellis JH
AJR Am J Roentgenol; 2014 Apr; 202(4):784-9. PubMed ID: 24660707
[TBL] [Abstract][Full Text] [Related]
19. [Iodinated contrast media and nephropathy--new recommendations. Estimated creatine clearance for better assessment of renal function and dosage].
Nyman U; Hietala SO; Hellström M; Aspelin P; Björkdahl P; Albrechtsson U; Magnusson A; Måre K; Törnquist C; Ringertz H; Sterner G; Westberg G; Berne C
Lakartidningen; 2003 Mar; 100(10):840-3, 846-8. PubMed ID: 12680021
[No Abstract] [Full Text] [Related]
20. Contrast-induced nephropathy.
Persson PB
Eur Radiol; 2005 Nov; 15 Suppl 4():D65-9. PubMed ID: 16479650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
